The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding therapy preferences of cancer patients with the use of therapy preference scale.
 
Prajwal Dhakal
No Relationships to Disclose
 
Christopher S Wichman
No Relationships to Disclose
 
Bunny J Pozehl
No Relationships to Disclose
 
Julie Vose
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Epizyme; Janssen Scientific Affairs; Kite/Gilead; Legend Biotech; Miltenyi Biotec; Novartis; Vaniam Group; Verastem
Consulting or Advisory Role - Bio Connections
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Seagen (Inst)
 
Gregory Bociek
Employment - Innate Pharma
Consulting or Advisory Role - Celgene; Innate Pharma
 
Vijaya Raj Bhatt
Consulting or Advisory Role - Abbvie; Agios; CSL Behring; Incyte; Partner Therapeutics; Pfizer
Research Funding - Incyte; National Marrow Donor Program; Tolero Pharmaceuticals